/PRNewswire/ DelveInsight s Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation.
The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) Director Daniel K. Spiegelman sold 3,788 shares of Myriad Genetics stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $22.04, for a total transaction of $83,487.52. Following the sale, the director now directly owns 36,705 shares in the company, […]
Southwest Colorado Cancer Survivor Celebration planned - The Pagosa Springs Sun pagosasun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pagosasun.com Daily Mail and Mail on Sunday newspapers.
QIAGEN And Myriad Genetics Develop Distributable Homologous Recombination Deficiency Test For Global Research And Companion Diagnostics Applications menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.